Study to assess Mirena user continuation and satisfaction for Contraception In InDian Subjects
Phase 4
Completed
- Conditions
- Health Condition 1: null- Contraception
- Registration Number
- CTRI/2014/02/004438
- Lead Sponsor
- Bayer Zydus Pharma Private Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
· Subject aged between 18-49 years who are initiating LNG IUS
therapy for contraception
· Subject willing to provide informed consent and comply with study
procedure
Exclusion Criteria
· Exclusion criteria must be read in conjunction with the local product
information.
The decision to initiate use of a LNG IUS for contraception is made
independently by the participant and her health care provider and is
not mandated by study design or protocol.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method